Eur Rev Med Pharmacol Sci 2016; 20 (5): 930-936

Serum levels of endocan, claudin-5 and cytokines in migraine

M. Yücel, D. Kotan, G. Gurol Çiftçi, I.H. Çiftçi, H.I. Cikriklar

Department of Emergency Medicine, Sakarya University, Faculty of Medicine, Sakarya, Turkey. drmrtycl@gmail.com


OBJECTIVE: Endothelial dysfunction is involved in inflammatory disorders, migration, angiogenesis, and tumor progression. There is a known relationship between migraine and inflammation; however, there are conflicting data as to whether there is a link between migraine and endothelial dysfunction. The current study aimed to determine the relationships between migraine and levels of serum Endocan (ESM-1), Claudin-5 (CLDN5), IL-1β, IL-6 and TNF-α levels, which are proven indicators of endothelial dysfunction and inflammation in patients with migraine.

PATIENTS AND METHODS: Thirty-one patients and 24 healthy subjects were included in this study. Participants underwent thorough physical and neurological evaluations, and levels of serum ESM-1, CLDN5, IL-1β, IL-6 and TNF-α were measured for each patient.

RESULTS: The levels of ESM-1, CLDN5, IL-1β, IL-6, and TNF-α were significantly higher in the migraine attack group than in the control group (p: 0.006, p: 0.002, p: 0.002, p: 0.003, p: 0.036, respectively). Additionally, there were significant differences in the ESM-1 levels of the visual analog scale (VAS) subgroup (p = 0.041), and there were moderate differences in the CLDN5 levels of the VAS subgroup (p = 0.064).

CONCLUSIONS: High serum levels of IL-1β, IL-6 and TNF-α in the migraine attack group indicate that inflammation plays a major role in migraine pathogenesis. In particular, the high ESM-1 and CLDN5 levels in patients with migraine suggest that inflammation should be investigated further, it may be a useful tool in the differential diagnosis of migraine.

Free PDF Download

To cite this article

M. Yücel, D. Kotan, G. Gurol Çiftçi, I.H. Çiftçi, H.I. Cikriklar
Serum levels of endocan, claudin-5 and cytokines in migraine

Eur Rev Med Pharmacol Sci
Year: 2016
Vol. 20 - N. 5
Pages: 930-936